UFF
ONC

USA Financial Formulas’s BeOne Medicines Ltd ONC Stock Holding History

USA Financial Formulas’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-76
Closed -$25.9K – 481
2025
Q3 		$25.9K Buy
+76
New +$23.1K ﹤0.01% 239

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

USA Financial Formulas's ONC Position: Q4 2025 in Review

USA Financial Formulas sold out of BeOne Medicines Ltd (ONC) in Q4 2025, closing a stake of 76 shares — an estimated $25.9K sold.

USA Financial Formulas first reported a position in ONC in Q3 2025 and held it in 1 quarter. The position peaked at $25.9K in Q3 2025. 286 funds tracked by Wall St. Rank hold ONC as of Q4 2025.

  • USA Financial Formulas reported no remaining BeOne Medicines Ltd position as of Q4 2025 after selling out during the quarter.
  • USA Financial Formulas sold 76 BeOne Medicines Ltd shares in Q4 2025, an estimated $25.9K.
  • USA Financial Formulas first reported a position in BeOne Medicines Ltd in Q3 2025 and held it in 1 quarter.
  • USA Financial Formulas's BeOne Medicines Ltd position peaked at $25.9K in Q3 2025.
  • 286 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2025.

Based on USA Financial Formulas's 13F filing for Q4 2025, filed 14 Jan 2026.